US Food and Drug Administration limits approval for new coronavirus vaccines to high-risk people
51
votes
Showing only topics with the tag "vaccines".
Back to normal view
-
-
A new type of vaccine is needle-free and doubles as dental floss
29 votes -
New mRNA vaccine shows promise in malaria prevention
13 votes -
Would you get sick in the name of science?
11 votes -
The obvious reason the US should not vaccinate like Denmark – it isn't Denmark
6 votes -
American Academy of Pediatrics (AAP) suing Health and Human Services (HHS) secretary Robert F. Kennedy Jr. over vaccine policy
30 votes -
‘I feel like I’ve been lied to’: When a measles outbreak hits home
33 votes -
The plan to vaccinate all Americans, despite Robert F. Kennedy Jr.
28 votes -
Canada achieved measles elimination status in 1998. Now, it could lose it.
36 votes -
US Food and Drug Administration to limit covid shot approval to elderly, those with medical conditions
52 votes -
Why you should also be aware of whooping cough amid US measles outbreak
17 votes -
Study finds strongest evidence yet that shingles vaccine helps cut dementia risk
31 votes -
Texas officials report that an unvaccinated child has died of measles
63 votes -
Robert F. Kennedy, Jr.: Texas measles outbreak is call to action for all of us. MMR vaccine is crucial to avoiding potentially deadly disease.
34 votes -
Measles outbreak mounts among children in one of Texas’ least vaccinated counties
25 votes -
US-developed drug formulation could eliminate cold storage for vaccines
11 votes -
Louisiana forbids public health workers from promoting COVID, flu and mpox shots
33 votes -
Battling infectious diseases in the 20th century: The impact of vaccines
12 votes -
HPV vaccination: How the world can eliminate cervical cancer
23 votes -
The flu shot is different this year, thanks to COVID
25 votes -
US Food and Drug Administration approves first nasal spray flu vaccine for use at home
23 votes -
First-ever mRNA vaccine halts pancreatic cancer in its tracks
50 votes -
New coronavirus vaccines are now approved
34 votes -
Second malaria vaccine launched in Ivory Coast marks new milestone
13 votes -
The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine
29 votes -
Gilead shot prevents all HIV cases in trial of African women
29 votes -
Reuters investigation: US Pentagon ran secret anti-vax campaign to undermine China during pandemic
110 votes -
mRNA melanoma vaccine halves the risk of death and recurrence
16 votes -
How did the world run so low on cholera vaccine? As outbreaks grow, stockpile runs dry.
12 votes -
US, European nations consider vaccinating workers exposed to bird flu
9 votes -
Genetics played a role in blood clots linked to COVID-19 shots
11 votes -
mRNA cancer vaccine reprograms immune system to tackle glioblastoma
12 votes -
Good news against Dengue
10 votes -
Lyme disease vaccine: Major test underway. All you need to know.
34 votes -
New York midwife fined for giving 1,500 children homeopathic pellets instead of vaccines
42 votes -
German man deliberately receives 217 Covid vaccinations over twenty-nine months, with no adverse events or strong effect on immune system
45 votes -
Progress deferred: Lessons from mRNA vaccine development
9 votes -
Cameroon starts world-first malaria mass vaccine rollout
18 votes -
Philadelphia health department warns of measles cluster among unvaccinated residents that originated with CHOP patient
18 votes -
Scientists explain why ‘doing your own research’ leads to believing conspiracies
42 votes -
World's first "self-amplifying" vaccine approved in Japan
15 votes -
Moderna, Merck vaccine with Keytruda cuts risk of deadly skin cancer returning in half, data says
9 votes -
New lifesaving malaria vaccines need to be available now
7 votes -
Despite new Respiratory Syncytial Virus shots, most older US adults remain unvaccinated
13 votes -
First malaria vaccine slashes early childhood mortality
12 votes -
New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes...
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs [...] found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication.
Professor Jonathan Heeney from Cambridge’s Department of Veterinary Medicine, who led the research, [said] “We wanted to come up with a vaccine that wouldn’t only protect against SARS-CoV-2, but all its relatives.”
18 votes -
“Inverse vaccine” shows potential to treat multiple sclerosis and other autoimmune diseases
48 votes -
Why we didn’t get a malaria vaccine sooner
6 votes -
The impact of vaccines and behavior on US cumulative deaths from COVID-19
9 votes -
The body’s immune system responding to a COVID vaccine, and not the vaccine itself, is likely the cause of menstrual cycle changes experienced after vaccination
42 votes